Details for New Drug Application (NDA): 012104
✉ Email this page to a colleague
NDA 012104 describes KENALOG, which is a drug marketed by Delcor Asset Corp, Sun Pharm Inds Inc, and Apothecon, and is included in nine NDAs. It is available from one supplier. Additional details are available on the KENALOG profile page.
The generic ingredient in KENALOG is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in KENALOG is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 012104
| Tradename: | KENALOG |
| Applicant: | Sun Pharm Inds Inc |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Pharmacology for NDA: 012104
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 012104
Suppliers and Packaging for NDA: 012104
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| KENALOG | triamcinolone acetonide | SPRAY;TOPICAL | 012104 | NDA | Sun Pharmaceutical Industries, Inc. | 10631-093 | 10631-093-07 | 100 g in 1 CAN (10631-093-07) |
| KENALOG | triamcinolone acetonide | SPRAY;TOPICAL | 012104 | NDA | Sun Pharmaceutical Industries, Inc. | 10631-093 | 10631-093-62 | 63 g in 1 CAN (10631-093-62) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY;TOPICAL | Strength | 0.147MG/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
